Literature DB >> 15526431

The effects of substance P after central administration on the activity of the mesolimbic system of the rat brain as studied by microdialysis.

S V Nikolaev1, A A Lebedev, E R Bychkov, A V Oblyapin, S A Dambinova, P D Shabanov.   

Abstract

In vivo microdialysis was used to study the effects of substance P on dopamine, dihydroxyphenylacetic acid, and homovanillic acid levels in the nucleus accumbens in rats. Each animal received sequential injections of physiological saline, 0.1 microg of substance P, and 1 microg of substance P into the lateral ventricle over three days. Dialysates showed increases in dopamine levels in response to neuropeptide, by 41% for the 0.1 microg dose and 71% for the 1 microg dose. The dynamics of these changes also depended on the concentration of the agent. Administration of 1 microg of substance P gave a peak dopamine level at 50 min; the neurotransmitter level remained significantly elevated 75 min after dosage with substance P. The dopamine level was increased only at 75 min when the 0.1 microg dose of neuropeptide was used. Changes in metabolite levels were also dose-dependent. After the 1 microg dose, the dihydroxyphenylacetic acid level increased by 28%, while the 0.1 microg dose produced no significant change in the level of this metabolite. The homovanillic acid level did not respond to administration of substance P at either dose. These data support the suggestion that the influence of substance P on the internal compensation system is to a significant extent mediated by dopaminergic mechanisms and provides a possible explanation for the effects of the neuropeptide seen in a conditioned place preference reflex.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526431     DOI: 10.1023/b:neab.0000036016.65208.27

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  19 in total

1.  In vivo metabolism and clearance of substance P and co-expressed tachykinins in rat striatum.

Authors:  A T Michael-Titus; K Fernandes; H Setty; R Whelpton
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 2.  Receptors and antagonists for substance P and related peptides.

Authors:  D Regoli; A Boudon; J L Fauchére
Journal:  Pharmacol Rev       Date:  1994-12       Impact factor: 25.468

Review 3.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

Authors:  T M Tzschentke
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

4.  Naloxone blocks conditioned place preference induced by substance P and [pGlu6]-SP(6-11).

Authors:  R U Hasenöhrl; P Gerhardt; J P Huston
Journal:  Regul Pept       Date:  1991-09-03

Review 5.  Drug delivery to the brain.

Authors:  W M Pardridge
Journal:  J Cereb Blood Flow Metab       Date:  1997-07       Impact factor: 6.200

Review 6.  Substance p.

Authors:  S Harrison; P Geppetti
Journal:  Int J Biochem Cell Biol       Date:  2001-06       Impact factor: 5.085

Review 7.  Neuroanatomical localisation of Substance P in the CNS and sensory neurons.

Authors:  A Ribeiro-da-Silva; T Hökfelt
Journal:  Neuropeptides       Date:  2000-10       Impact factor: 3.286

8.  Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor.

Authors:  S Nikolaus; J P Huston; R U Hasenöhrl
Journal:  Eur J Pharmacol       Date:  1999-04-09       Impact factor: 4.432

Review 9.  Substance P receptor (NK-1) in the central nervous system: possible functions from a morphological aspect.

Authors:  H Kiyama; H Maeno; M Tohyama
Journal:  Regul Pept       Date:  1993-07-02

10.  Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects.

Authors:  B H Westerink; J B De Vries
Journal:  J Neurochem       Date:  1988-09       Impact factor: 5.372

View more
  2 in total

1.  Substance P inhibits GABAB receptor signalling in the ventral tegmental area.

Authors:  Yan-Fang Xia; Elyssa B Margolis; Gregory O Hjelmstad
Journal:  J Physiol       Date:  2010-03-15       Impact factor: 5.182

2.  Responses of limbic and extrapyramidal substance P systems to nicotine treatment.

Authors:  Mario E Alburges; Paul S Frankel; Amanda J Hoonakker; Glen R Hanson
Journal:  Psychopharmacology (Berl)       Date:  2008-09-05       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.